Pharmaceutical Crystals

The crystalline state is the most commonly used essential solid active pharmaceutical ingredient (API). The characterization of pharmaceutical crystals encompasses many scientific disciplines, but the core is crystal structure analysis, which reveals the molecular structure of essential pharmaceutic...

Full description

Saved in:
Bibliographic Details
:
Year of Publication:2020
Language:English
Physical Description:1 electronic resource (148 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993548479304498
ctrlnum (CKB)4100000011302223
(oapen)https://directory.doabooks.org/handle/20.500.12854/56130
(EXLCZ)994100000011302223
collection bib_alma
record_format marc
spelling Uekusa, Hidehiro auth
Pharmaceutical Crystals
MDPI - Multidisciplinary Digital Publishing Institute 2020
1 electronic resource (148 p.)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
The crystalline state is the most commonly used essential solid active pharmaceutical ingredient (API). The characterization of pharmaceutical crystals encompasses many scientific disciplines, but the core is crystal structure analysis, which reveals the molecular structure of essential pharmaceutical compounds. Crystal structure analysis provides important structural information related to the API's wide range of physicochemical properties, such as solubility, stability, tablet performance, color, and hygroscopicity. This book entitled “Pharmaceutical Crystals"" focuses on the relationship between crystal structure and physicochemical properties. In particular, the new crystal structure of pharmaceutical compounds involving multi-component crystals, such as co-crystals, salts, and hydrates, and polymorph crystals are reported. Such crystal structures were investigated in the latest studies that combined morphology, spectroscopic, theoretical calculation, and thermal analysis with crystallographic study. This book highlights the importance of crystal structure information in many areas of pharmaceutical science and presents current trends in the structure–property study of pharmaceutical crystals. The Guest Editors of this book hope the readers enjoy a wide variety of recent studies on Pharmaceutical Crystals.
English
crystal structure analysis
famotidine
solution crystallization
salt optimization
structure determination from powder diffraction data
Hirshfeld surface analysis
DFT
molecular docking study
melting diagram
dehydration
hygroscopicity
HBV
Benzodioxole
pharmaceutical crystals
4-b]indol-4-one
pyrimidin-4(3H)-one
liquid assisted grinding
HOMO-LUMO
dissolution
cocrystal formation
Raman spectroscopy
carbamazepine
hydrogen bonding
3
ondansetron
physicochemical properties
solubility
succinic acid
cocrystal
adefovir dipivoxil
hepatitis B
polymorphs
hydrogen-bond-acceptance ability
DFT study
Nitrofurantoin-4-dimethylaminopyridine (NF-DMAP) salt
photostability
on-line monitoring
5-dihydro-4H-pyrimido[5
Imidazole
Semicarbazone
crystal habit
Crystal structure
solvent-mediated polymorphic transformation
ticagrelor
hydrate
pharmaceutical cocrystal
malonic acid
1H-indole
reactivity descriptors
famoxadone
crystal structure
dicarboxylic acid
hydrogen bond
saccharin
3-03928-712-5
Yonemochi, Etsuo auth
language English
format eBook
author Uekusa, Hidehiro
spellingShingle Uekusa, Hidehiro
Pharmaceutical Crystals
author_facet Uekusa, Hidehiro
Yonemochi, Etsuo
author_variant h u hu
author2 Yonemochi, Etsuo
author2_variant e y ey
author_sort Uekusa, Hidehiro
title Pharmaceutical Crystals
title_full Pharmaceutical Crystals
title_fullStr Pharmaceutical Crystals
title_full_unstemmed Pharmaceutical Crystals
title_auth Pharmaceutical Crystals
title_new Pharmaceutical Crystals
title_sort pharmaceutical crystals
publisher MDPI - Multidisciplinary Digital Publishing Institute
publishDate 2020
physical 1 electronic resource (148 p.)
isbn 3-03928-713-3
3-03928-712-5
illustrated Not Illustrated
work_keys_str_mv AT uekusahidehiro pharmaceuticalcrystals
AT yonemochietsuo pharmaceuticalcrystals
status_str n
ids_txt_mv (CKB)4100000011302223
(oapen)https://directory.doabooks.org/handle/20.500.12854/56130
(EXLCZ)994100000011302223
carrierType_str_mv cr
is_hierarchy_title Pharmaceutical Crystals
author2_original_writing_str_mv noLinkedField
_version_ 1796652141132120064
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03991nam-a2200925z--4500</leader><controlfield tag="001">993548479304498</controlfield><controlfield tag="005">20231214132832.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202102s2020 xx |||||o ||| 0|eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3-03928-713-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4100000011302223</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/56130</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994100000011302223</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Uekusa, Hidehiro</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmaceutical Crystals</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (148 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The crystalline state is the most commonly used essential solid active pharmaceutical ingredient (API). The characterization of pharmaceutical crystals encompasses many scientific disciplines, but the core is crystal structure analysis, which reveals the molecular structure of essential pharmaceutical compounds. Crystal structure analysis provides important structural information related to the API's wide range of physicochemical properties, such as solubility, stability, tablet performance, color, and hygroscopicity. This book entitled “Pharmaceutical Crystals"" focuses on the relationship between crystal structure and physicochemical properties. In particular, the new crystal structure of pharmaceutical compounds involving multi-component crystals, such as co-crystals, salts, and hydrates, and polymorph crystals are reported. Such crystal structures were investigated in the latest studies that combined morphology, spectroscopic, theoretical calculation, and thermal analysis with crystallographic study. This book highlights the importance of crystal structure information in many areas of pharmaceutical science and presents current trends in the structure–property study of pharmaceutical crystals. The Guest Editors of this book hope the readers enjoy a wide variety of recent studies on Pharmaceutical Crystals.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">crystal structure analysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">famotidine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">solution crystallization</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">salt optimization</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">structure determination from powder diffraction data</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Hirshfeld surface analysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">DFT</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">molecular docking study</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">melting diagram</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dehydration</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hygroscopicity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HBV</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Benzodioxole</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pharmaceutical crystals</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">4-b]indol-4-one</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pyrimidin-4(3H)-one</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">liquid assisted grinding</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HOMO-LUMO</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dissolution</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cocrystal formation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Raman spectroscopy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">carbamazepine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hydrogen bonding</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">3</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ondansetron</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">physicochemical properties</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">solubility</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">succinic acid</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cocrystal</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">adefovir dipivoxil</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hepatitis B</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">polymorphs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hydrogen-bond-acceptance ability</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">DFT study</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Nitrofurantoin-4-dimethylaminopyridine (NF-DMAP) salt</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">photostability</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">on-line monitoring</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">5-dihydro-4H-pyrimido[5</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Imidazole</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Semicarbazone</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">crystal habit</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Crystal structure</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">solvent-mediated polymorphic transformation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ticagrelor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hydrate</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pharmaceutical cocrystal</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">malonic acid</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">1H-indole</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">reactivity descriptors</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">famoxadone</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">crystal structure</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dicarboxylic acid</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hydrogen bond</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">saccharin</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03928-712-5</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yonemochi, Etsuo</subfield><subfield code="4">auth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:32:58 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2020-06-20 22:16:43 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5338866380004498&amp;Force_direct=true</subfield><subfield code="Z">5338866380004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338866380004498</subfield></datafield></record></collection>